Gefitinib induces myeloid differentiation of acute myeloid leukemia

Cure rates for patients with acute myeloid leukemia (AML) remain low despite ever-increasing dose intensity of cytotoxic therapy. In an effort to identify novel approaches to AML therapy, we recently reported a new method of chemical screening based on the modulation of a gene expression signature o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Stegmaier, Kimberly, Corsello, Steven M., Ross, Kenneth N., Wong, Jenny S., DeAngelo, Daniel J., Golub, Todd R.
Format: Artigo
Idioma:Inglês
Publicat: The American Society of Hematology 2005
Matèries:
Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895296/
https://ncbi.nlm.nih.gov/pubmed/15998836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-02-0488
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars